Active Ingredient Insulin Glargine
Active Ingredient Details
What is Insulin Glargine?
A recombinant LONG ACTING INSULIN and HYPOGLYCEMIC AGENT that is used to manage BLOOD GLUCOSE in patients with DIABETES MELLITUS.
How many products in the NDC database contain Insulin Glargine?
The NDC database has 36 products with the active ingredient Insulin Glargine. The following table lists all the products that have this active ingredient.
NDC Products with Insulin Glargine
NDC | Proprietary Name | Non-Proprietary Name | Dosage Form | Route Name | Company Name | Status | |
---|---|---|---|---|---|---|---|
0002-1076 | Proprietary Name: | Insulin Glargine | Injection, Solution | Eli Lilly And Company | ACTIVE | ||
0002-1437 | Proprietary Name: | Insulin Glargine | Injection, Solution | Eli Lilly And Company | ACTIVE | ||
0002-7715 | Proprietary Name: Basaglar KwikPen | Insulin Glargine | Injection, Solution | Subcutaneous | Eli Lilly And Company | ACTIVE | |
0002-8214 | Proprietary Name: Basaglar Tempo Pen | Insulin Glargine | Injection, Solution | Subcutaneous | Eli Lilly And Company | ACTIVE | |
0002-8980 | Proprietary Name: Rezvoglar KwikPen | Insulin Glargine-aglr | Injection, Solution | Subcutaneous | Eli Lilly And Company | ACTIVE | |
0002-9524 | Proprietary Name: | Insulin Glargine | Crystal | Eli Lilly And Company | ACTIVE | ||
0024-5761 | Proprietary Name: Soliqua 100/33 | Insulin Glargine And Lixisenatide | Injection, Solution | Subcutaneous | Sanofi-aventis U.s. Llc | ACTIVE | |
0024-5869 | Proprietary Name: Toujeo | Insulin Glargine | Injection, Solution | Subcutaneous | Sanofi-aventis U.s. Llc | ACTIVE | |
0024-5871 | Proprietary Name: Toujeo Max | Insulin Glargine | Injection, Solution | Subcutaneous | Sanofi-aventis U.s. Llc | ACTIVE | |
0088-2219 | Proprietary Name: Lantus Solostar | Insulin Glargine | Injection, Solution | Subcutaneous | Sanofi-aventis U.s. Llc | ACTIVE | |
0088-2220 | Proprietary Name: Lantus | Insulin Glargine | Injection, Solution | Subcutaneous | Sanofi-aventis U.s. Llc | ACTIVE | |
0088-5020 | Proprietary Name: Lantus Solostar | Insulin Glargine | Injection, Solution | Subcutaneous | Sanofi-aventis U.s. Llc | ACTIVE | |
0088-5021 | Proprietary Name: Lantus | Insulin Glargine | Injection, Solution | Subcutaneous | Sanofi-aventis U.s. Llc | ACTIVE | |
0955-1728 | Proprietary Name: Insulin Glargine Solostar | Insulin Glargine | Injection, Solution | Subcutaneous | Winthrop U.s. | ACTIVE | |
0955-1729 | Proprietary Name: Insulin Glargine | Insulin Glargine | Injection, Solution | Subcutaneous | Winthrop U.s. | ACTIVE | |
0955-2900 | Proprietary Name: Insulin Glargine U-300 Max | Insulin Glargine | Injection, Solution | Subcutaneous | Winthrop U.s, A Business Of Sanofi-aventis U.s. Llc | ACTIVE | |
0955-3900 | Proprietary Name: Insulin Glargine U-300 | Insulin Glargine | Injection, Solution | Subcutaneous | Winthrop U.s, A Business Of Sanofi-aventis U.s. Llc | ACTIVE | |
49502-250 | Proprietary Name: Semglee | Insulin Glargine-yfgn | Injection, Solution | Subcutaneous | Mylan Specialty L.p. | ACTIVE | |
49502-251 | Proprietary Name: Semglee | Insulin Glargine-yfgn | Injection, Solution | Subcutaneous | Mylan Specialty L.p. | ACTIVE | |
49502-393 | Proprietary Name: Insulin Glargine | Insulin Glargine-yfgn | Injection, Solution | Subcutaneous | Mylan Specialty L.p. | ACTIVE | |
49502-394 | Proprietary Name: Insulin Glargine | Insulin Glargine-yfgn | Injection, Solution | Subcutaneous | Mylan Specialty L.p. | ACTIVE | |
50090-0876 | Proprietary Name: Lantus | Insulin Glargine | Injection, Solution | Subcutaneous | A-s Medication Solutions | ACTIVE | |
50090-1398 | Proprietary Name: Lantus Solostar | Insulin Glargine | Injection, Solution | Subcutaneous | A-s Medication Solutions | ACTIVE | |
50090-2193 | Proprietary Name: Toujeo | Insulin Glargine | Injection, Solution | Subcutaneous | A-s Medication Solutions | ACTIVE | |
50090-4068 | Proprietary Name: Lantus Solostar | Insulin Glargine | Injection, Solution | Subcutaneous | A-s Medication Solutions | ACTIVE | |
50090-4177 | Proprietary Name: Toujeo Max | Insulin Glargine | Injection, Solution | Subcutaneous | A-s Medication Solutions | ACTIVE | |
50090-6178 | Proprietary Name: Insulin Glargine Solostar | Insulin Glargine | Injection, Solution | Subcutaneous | A-s Medication Solutions | ACTIVE | |
50090-6184 | Proprietary Name: Insulin Glargine | Insulin Glargine | Injection, Solution | Subcutaneous | A-s Medication Solutions | ACTIVE | |
50090-6439 | Proprietary Name: Rezvoglar Kwikpen | Insulin Glargine-aglr | Injection, Solution | Subcutaneous | A-s Medication Solutions | ACTIVE | |
52221-125 | Proprietary Name: | Insulin Glargine | Powder | Amphastar Nanjing Pharmaceuticals, Inc. | ACTIVE | ||
54568-766 | Proprietary Name: | Insulin Glargine | Injection, Solution | Eli Lilly Italia Spa | ACTIVE | ||
62381-7661 | Proprietary Name: | Insulin Glargine | Injection, Solution | Lilly France | ACTIVE | ||
83257-011 | Proprietary Name: Semglee | Insulin Glargine-yfgn | Injection, Solution | Subcutaneous | Biocon Biologics Inc. | ACTIVE | |
83257-012 | Proprietary Name: Semglee | Insulin Glargine-yfgn | Injection, Solution | Subcutaneous | Biocon Biologics Inc. | ACTIVE | |
83257-014 | Proprietary Name: Insulin Glargine | Insulin Glargine-yfgn | Injection, Solution | Subcutaneous | Biocon Biologics Inc. | ACTIVE | |
83257-015 | Proprietary Name: Insulin Glargine | Insulin Glargine-yfgn | Injection, Solution | Subcutaneous | Biocon Biologics Inc. | ACTIVE |